| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1053/J.SEMINONCOL.2004.04.021 |
| P698 | PubMed publication ID | 15297938 |
| P2093 | author name string | Alfred I Neugut | |
| Katherine D Crew | |||
| P433 | issue | 4 | |
| P921 | main subject | epidemiology | Q133805 |
| P304 | page(s) | 450-464 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Seminars in Oncology | Q14330412 |
| P1476 | title | Epidemiology of upper gastrointestinal malignancies | |
| P478 | volume | 31 |
| Q90099882 | A Comparison of Biopsy and Mucosal Swab Specimens for Examining the Microbiota of Upper Gastrointestinal Carcinoma |
| Q47896331 | A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer |
| Q52674735 | A genetic polymorphism at miR-526b binding-site in the lincRNA-NR_024015 exon confers risk of esophageal squamous cell carcinoma in a population of North China. |
| Q50943511 | A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer. |
| Q39745780 | A survey of oesophageal cancer: pathology, stage and clinical presentation |
| Q57846070 | Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome |
| Q53114535 | Adherence to Mediterranean-style dietary pattern and risk of esophageal squamous cell carcinoma: a case-control study in Iran. |
| Q38034225 | Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensus |
| Q36144148 | Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma |
| Q34581372 | Animal models of stomach carcinogenesis |
| Q37885725 | Anti-HER agents in gastric cancer: from bench to bedside |
| Q40304345 | Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus |
| Q38270899 | Apatinib for the treatment of gastric cancer |
| Q40444383 | Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population. |
| Q44056952 | Association of a tgf-b1-509c/t polymorphism with gastric cancer risk: a meta-analysis |
| Q53670271 | Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China. |
| Q40165764 | B-cell specific Moloney leukemia virus insert site 1 and peptidyl arginine deiminase IV positively regulate carcinogenesis and progression of esophageal squamous cell carcinoma |
| Q41082538 | CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma |
| Q33397356 | Capecitabine for the treatment for advanced gastric cancer: efficacy, safety and ethnicity |
| Q37136996 | Capecitabine in the treatment of advanced gastric cancer |
| Q36997120 | Carbohydrates and cancer: an overview of the epidemiological evidence |
| Q35195015 | Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays |
| Q38541163 | Chemokines and their receptors in esophageal cancer--the systematic review and future perspectives |
| Q24236634 | Chemotherapy for advanced gastric cancer |
| Q24244040 | Chemotherapy for advanced gastric cancer |
| Q38604012 | Chemotherapy for advanced gastric cancer. |
| Q36548725 | Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel |
| Q47547459 | Chitosan/poly (lactic acid)-coated piceatannol nanoparticles exert an in vitro apoptosis activity on liver, lung and breast cancer cell lines |
| Q37305467 | Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression |
| Q26862365 | Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach |
| Q80585389 | Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients |
| Q59843785 | Comparative Evaluation of Serum C-Reactive Protein (CRP) Levels in the Different Histological Subtypes of Esophageal Cancer (Squamous Cell Carcinoma and Adenocarcinoma of Esophagus) |
| Q53315728 | Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma. |
| Q33868284 | Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma |
| Q35097685 | Diagnostic value of multiple tumor markers for patients with esophageal carcinoma |
| Q36616503 | Docetaxel in the treatment of gastric cancer |
| Q39709386 | Down-regulation of microRNA 10a expression in esophageal squamous cell carcinoma cells. |
| Q38751892 | Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort |
| Q37524565 | EBNA1 binding and epigenetic regulation of gastrokine tumor suppressor genes in gastric carcinoma cells |
| Q58573014 | Effects of PLK1 on proliferation, invasion and metastasis of gastric cancer cells through epithelial-mesenchymal transition |
| Q35578761 | Effects of Two Common Polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on Gastric Cancer Susceptibility |
| Q39226030 | Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer |
| Q38284597 | Emerging mAbs for the treatment of esophagogastric cancer |
| Q38110962 | Emerging tyrosine kinase inhibitors for esophageal cancer |
| Q51754022 | Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. |
| Q26853636 | Endoscopic submucosal dissection in early gastric cancer in elderly patients and comorbid conditions |
| Q36172082 | Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma |
| Q37169303 | Esophageal adenocarcinoma arising in Barrett esophagus |
| Q45226340 | Esophagogastric junction adenocarcinoma: multivariate analyses of surgical morbi-mortality and adjuvant therapy |
| Q42407540 | Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction |
| Q83018257 | Exposure to both radiation and chemotherapy increases the risk of Barrett's and multilayered epithelium |
| Q40235170 | Expression and Clinicopathological Significance of Mel-18 and Bmi-1 in Esophageal Squamous Cell Carcinoma |
| Q36610306 | Familial risk for gastric carcinoma: an updated study from Sweden |
| Q37558800 | Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case-control study |
| Q28082921 | From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer |
| Q36611689 | Functional epidermal growth factor gene polymorphisms and risk of gastric cancer |
| Q34550843 | Functional promoter -308G>A variant in tumor necrosis factor α gene is associated with risk and progression of gastric cancer in a Chinese population |
| Q53226854 | Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population. |
| Q34448574 | Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer |
| Q84752491 | Genetic variation in PLCE1 is associated with gastric cancer survival in a Chinese population |
| Q45760903 | HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression |
| Q37784464 | High rates of advanced gastric cancer in community of Flushing, New York |
| Q35181361 | Histone deacetylase HDAC4 promotes gastric cancer SGC-7901 cells progression via p21 repression. |
| Q36613517 | Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas |
| Q37138358 | Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada -- an epidemiological study from 1964-2002 |
| Q34075192 | Infiltration of alternatively activated macrophages in cancer tissue is associated with MDSC and Th2 polarization in patients with esophageal cancer. |
| Q38748837 | Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity. |
| Q47157603 | Investigation of the association between the MDM2 T309G polymorphism and gastric cancer |
| Q37079108 | Locally advanced and metastatic gastric cancer: current management and new treatment developments |
| Q36699232 | Long-term outcomes and prognostic factors for patients with esophageal cancer following radiotherapy |
| Q34602737 | MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis |
| Q37642780 | ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer |
| Q38227841 | Metabolomic studies of human gastric cancer: review |
| Q39572326 | MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells |
| Q37988359 | MicroRNA and its roles in esophageal cancer. |
| Q34102917 | MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival |
| Q89272213 | Multimodal treatment in locally advanced gastric cancer |
| Q37338260 | Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction |
| Q42951422 | Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis |
| Q26738548 | New advances in targeted gastric cancer treatment |
| Q35229996 | New coil concept for endoluminal MR imaging: initial results in staging of gastric carcinoma in correlation with histopathology |
| Q33583799 | New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry |
| Q43194168 | Novel Endoscopic Techniques for the Detection of Barrett's Dysplasia. |
| Q38019657 | Novel targeted agents for gastric cancer |
| Q33268091 | Oesophageal cancer mortality in Spain: a spatial analysis |
| Q38072285 | Oesophageal cancer--an overview |
| Q46217013 | Polymorphism Arg290Arg in esophageal-cancer-related gene 1 (ECRG1) is a prognostic factor for survival in esophageal cancer |
| Q41233517 | Polymorphisms of VDR gene and risk of gastric cardiac adenocarcinoma in Chinese population |
| Q45416456 | Predicting the probability of mortality of gastric cancer patients using decision tree. |
| Q36022348 | Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation |
| Q36636695 | Predictive and prognostic molecular markers in outcome of esophageal cancer |
| Q36475989 | Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer |
| Q53361856 | Prevalence and clinicopathologic characteristics of gastric cardia cancer in South Korea. |
| Q37198637 | Principles of modern radiation techniques for esophageal and gastroesophageal junction cancers. |
| Q41055901 | Prognosis of surgery combined with different adjuvant therapies in esophageal cancer treatment: a network meta-analysis |
| Q37261067 | Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States |
| Q34133427 | Proposed follow up programme after curative resection for lower third oesophageal cancer |
| Q38830382 | Prospective study of serum cysteine and cysteinylglycine and cancer of the head and neck, esophagus, and stomach in a cohort of male smokers |
| Q30251478 | Recent advances in proximal gastric carcinoma |
| Q36376439 | Recent developments in the systemic therapy of advanced gastroesophageal malignancies |
| Q35445166 | Refining docetaxel-containing therapy for gastric cancer. |
| Q35579521 | Renal dysfunction is an independent risk factor for bleeding after gastric ESD |
| Q90221209 | Resveratrol inhibits the growth of gastric cancer via the Wnt/β-catenin pathway |
| Q36815205 | Risk factors and risk reduction of malignant seeding of the percutaneous endoscopic gastrostomy track from pharyngoesophageal malignancy: a review of all 44 known reported cases |
| Q84775921 | Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study |
| Q35761399 | Risk of oesophageal cancer by histology among patients hospitalised for gastroduodenal ulcers |
| Q51352197 | SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma. |
| Q41640117 | SIRT3 inhibits cell proliferation in human gastric cancer through down-regulation of Notch-1. |
| Q92591788 | Screening and Identification of Molecular Targets Involved in Preventing Gastric Precancerous Lesions in Chronic Atrophic Gastritis by Qilianshupi Decoction |
| Q42844662 | Second gastric cancers among patients with primary sporadic and familial cancers in Sweden |
| Q81898769 | Sensitivity of ultrasonography for gastric cancer diagnosis in symptomatic patients |
| Q36400378 | Seom guidelines for the treatment of gastric cancer 2015. |
| Q26779217 | State of the art management of metastatic gastroesophageal cancer |
| Q47159246 | Stem cell factor in the serum of patients with esophageal cancer in relation to its histological types |
| Q87690590 | Stromal expression of carbonic anhydrase IX in esophageal cancer |
| Q48687568 | Surgical Treatment of High-Grade Dysplasia and Early Esophageal Cancer |
| Q38627318 | Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum |
| Q46207839 | Survival benefit of neoadjuvant versus adjuvant radiotherapy in lymph node positive esophageal cancer: a population based analysis |
| Q27693303 | Systematic review of laparoscopy-assisted versus open gastrectomy for advanced gastric cancer |
| Q54235676 | TGF-α gene variations and increased susceptibility of gastric cancer in an Eastern Chinese Han population. |
| Q34113668 | The DNA repair gene APE1 T1349G polymorphism and risk of gastric cancer in a Chinese population |
| Q36693716 | The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer |
| Q36567902 | The Traditional Chinese Medicine Baicalein Potently Inhibits Gastric Cancer Cells |
| Q36606582 | The Trend in Histological Changes and the Incidence of Esophagus Cancer in Iran (2003-2008). |
| Q54615935 | The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma. |
| Q33718863 | The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort |
| Q53286921 | The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma. |
| Q54336219 | The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. |
| Q82462124 | The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation |
| Q38166249 | The role of glycogen synthase kinase 3-β in immunity and cell cycle: implications in esophageal cancer |
| Q36611932 | The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands |
| Q37246675 | Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. |
| Q36281593 | Unique Clinicopathology of Proximal Gastric Carcinoma: A Critical Review |
| Q53334675 | Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. |
| Q64070093 | and digestive system cancers |
Search more.